422 related articles for article (PubMed ID: 16857392)
1. Novel probabilistic method for precisely correcting the QT interval for heart rate in telemetered dogs and cynomolgus monkeys.
Holzgrefe HH; Cavero I; Gleason CR; Warner WA; Buchanan LV; Gill MW; Burkett DE; Durham SK
J Pharmacol Toxicol Methods; 2007; 55(2):159-75. PubMed ID: 16857392
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the nonclinical telemetered ECG: impact of logging rate and RR bin width in the dog and cynomolgus monkey.
Holzgrefe HH; Cavero I; Gleason CR
J Pharmacol Toxicol Methods; 2007; 56(1):34-42. PubMed ID: 17258913
[TBL] [Abstract][Full Text] [Related]
3. Application of probabilistic analysis for precisely correcting the QT interval for heart rate in telemetered common marmosets.
Honda M; Komatsu R; Holzgrefe HH; Yamada Y; Isobe T; Kimura K; Itoh T; Tamaoki N; Tabo M
J Pharmacol Toxicol Methods; 2010; 61(3):264-70. PubMed ID: 20097297
[TBL] [Abstract][Full Text] [Related]
4. Application of a probabilistic method for the determination of drug-induced QT prolongation in telemetered cynomolgus monkeys: effects of moxifloxacin.
Holzgrefe HH; Cavero I; Buchanan LV; Gill MW; Durham SK
J Pharmacol Toxicol Methods; 2007; 55(3):227-37. PubMed ID: 17097307
[TBL] [Abstract][Full Text] [Related]
5. Preclinical QT safety assessment: cross-species comparisons and human translation from an industry consortium.
Holzgrefe H; Ferber G; Champeroux P; Gill M; Honda M; Greiter-Wilke A; Baird T; Meyer O; Saulnier M
J Pharmacol Toxicol Methods; 2014; 69(1):61-101. PubMed ID: 23689033
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of QT interval using a linear model in individual cynomolgus monkeys.
Koga T; Kuwano K; Kito G; Kanefuji K
J Pharmacol Toxicol Methods; 2007; 55(3):248-53. PubMed ID: 17141531
[TBL] [Abstract][Full Text] [Related]
7. A method for QT correction based on beat-to-beat analysis of the QT/RR interval relationship in conscious telemetred beagle dogs.
Batey AJ; Doe CP
J Pharmacol Toxicol Methods; 2002; 48(1):11-9. PubMed ID: 12750037
[TBL] [Abstract][Full Text] [Related]
8. Calculation of QT shift in non clinical safety pharmacology studies.
Champeroux P; Martel E; Fowler JS; Maurin A; Sola ML; Jude S; Elamrani F; Weyn AA; Laveissiere A; Lala P; Richard S
J Pharmacol Toxicol Methods; 2009; 59(2):73-85. PubMed ID: 19135537
[TBL] [Abstract][Full Text] [Related]
9. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.
Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ
Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131
[TBL] [Abstract][Full Text] [Related]
10. Importance of subject-specific QT/RR curvatures in the design of individual heart rate corrections of the QT interval.
Malik M; Hnatkova K; Kowalski D; Keirns JJ; van Gelderen EM
J Electrocardiol; 2012; 45(6):571-81. PubMed ID: 22999325
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a new formula for QT interval correction using a large colony of cynomolgus monkeys.
Nakayama S; Koie H; Kato-Tateishi M; Pai C; Ito-Fujishiro Y; Kanayama K; Sankai T; Yasutomi Y; Ageyama N
Exp Anim; 2020 Jan; 69(1):18-25. PubMed ID: 31308302
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the human QT interval: novel distribution-based assessment of the repolarization effects of moxifloxacin.
Holzgrefe HH; Ferber G; Morrison R; Meyer O; Greiter-Wilke A; Singer T
J Clin Pharmacol; 2012 Aug; 52(8):1222-39. PubMed ID: 21659628
[TBL] [Abstract][Full Text] [Related]
13. Correction of QT values to allow for increases in heart rate in conscious Beagle dogs in toxicology assessment.
Tattersall ML; Dymond M; Hammond T; Valentin JP
J Pharmacol Toxicol Methods; 2006; 53(1):11-9. PubMed ID: 15886026
[TBL] [Abstract][Full Text] [Related]
14. Heart rate correction models to detect QT interval prolongation in novel pharmaceutical development.
Markert M; Shen R; Trautmann T; Guth B
J Pharmacol Toxicol Methods; 2011; 64(1):25-41. PubMed ID: 21635956
[TBL] [Abstract][Full Text] [Related]
15. Assessing QT prolongation and electrocardiography restitution using a beat-to-beat method.
Fossa AA; Zhou M
Cardiol J; 2010; 17(3):230-43. PubMed ID: 20535712
[TBL] [Abstract][Full Text] [Related]
16. Validation and utility of the PhysioTel™ Digital M11 telemetry implant for cardiovascular data evaluation in cynomolgus monkeys and Beagle dogs.
Cordes JS; Heyen JR; Volberg ML; Poy N; Kreuser S; Shoieb AM; Steidl-Nichols J
J Pharmacol Toxicol Methods; 2016; 79():72-9. PubMed ID: 26844408
[TBL] [Abstract][Full Text] [Related]
17. QT prolongation modifies dynamic restitution and hysteresis of the beat-to-beat QT-TQ interval relationship during normal sinus rhythm under varying states of repolarization.
Fossa AA; Wisialowski T; Crimin K
J Pharmacol Exp Ther; 2006 Feb; 316(2):498-506. PubMed ID: 16204470
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic-pharmacodynamic modelling of the effect of Moxifloxacin on QTc prolongation in telemetered cynomolgus monkeys.
Watson KJ; Gorczyca WP; Umland J; Zhang Y; Chen X; Sun SZ; Fermini B; Holbrook M; Van Der Graaf PH
J Pharmacol Toxicol Methods; 2011; 63(3):304-13. PubMed ID: 21419854
[TBL] [Abstract][Full Text] [Related]
19. The relationship of clinical QT prolongation to outcome in the conscious dog using a beat-to-beat QT-RR interval assessment.
Fossa AA; DePasquale MJ; Raunig DL; Avery MJ; Leishman DJ
J Pharmacol Exp Ther; 2002 Aug; 302(2):828-33. PubMed ID: 12130750
[TBL] [Abstract][Full Text] [Related]
20. How many cardiac cycles must be measured to permit accurate RR, QT, and QTc estimates in conscious dogs?
Hamlin RL; Kijtawornrat A; Keene BW
J Pharmacol Toxicol Methods; 2004; 50(2):103-8. PubMed ID: 15385084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
